Clinical Trial

Transcriptomic Responses for the Identification of Pathogens

Study acronym: TRiP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
Acute undifferentiated febrile infection (AUFI) is a common presenting syndrome in low-resource settings and better diagnostics are urgently needed to improve patient management and guide disease prevention interventions. Assessment of the host gene expression response to infection in endemic populations has demonstrated significant promise as a new approach to identifying patients with enteric fever and for potential in differentiating between other causes of AUFI. Signatures identified through new data analytic techniques could be developed into a point-of-care test for use in endemic settings. In this multisite diagnostic evaluation study we will collect prospective clinical, laboratory and diagnostic data from two endemic settings to evaluate host gene expression signatures for detecting enteric fever and for determining the cause of AUFI in LMIC settings.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-05-05; most recent amendment 2025-02-26.
Status change: Not Yet Recruiting → Recruiting 2022-06-15
Trial Details
NCT Number NCT04878549
Lead Sponsor University of Sheffield
Collaborators: Christian Medical College, Vellore, India, KEMRI-Wellcome Trust Collaborative Research Program
Conditions Enteric Fever, Acute Febrile Illness, Typhoid, Paratyphoid Fever, Fever
Enrollment 2,000 participants
Start Date 2022-05-02
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2025-03-03